FDA and industry offer compromise "least burdensome" paper
This article was originally published in Clinica
Executive Summary
A small group from US industry and the FDA have agreed to a compromise proposal for dealing with the long-simmering dispute over how the agency should comply with the so-called "least burdensome" provision of the FDA Modernization Act of 1997 (FDAMA).